Dan Roberson

Urologic oncology fellow at the Mayo Clinic. Urology residency at the University of Pennsylvania. Passionate about caring for those with cancer.

[BackTable Urology @_backtableUro]

When should venous tumor thrombus in RCC be managed urgently?

This week, @vidit_sharma_ joins @DSRoberson93 to discuss embolic risk, patient optimization, and practical decision-making in managing venous tumor thrombus in renal cell carcinoma #URO300 @MayoUrology

https://t.co/bDyGNC92r8

[Urology Gold Journal @urogoldjournal]

A validated prediction tool is now available to assess metastatic recurrence risk post-surgery for non-metastatic renal cell carcinoma with venous tumor thrombus. https://t.co/5cGF8rf9d5 @UroOnc

[BackTable Urology @_backtableUro]

What do you do when metastatic urothelial cancer has a dramatic response to systemic therapy? This week, @abhinav__khanna and @DSRoberson93 discuss consolidative cystectomy and the evolving role of surgery in advanced disease #URO290

https://t.co/gX4CMpJaCj

[Abhinav Khanna @abhinav__khanna]

Good chat w/ great friends re: consolidative surgery in advanced urothelial carcinoma

An emerging paradigm of surgical consolidation opens an opportunity for cessation systemic therapy w/ definitive pathologic staging

Initial results @EuropeanUrology
with more data to come!

[GU Oncology Now @GUOncologyNow]

📺 In a new series, @DSRoberson93 and @abhinav__khanna of @MayoUrology and @NitinYerram of @HUMCUrology explore cytoreductive cystectomy in the post–EV-302 era.

👉 Learn how the success of EV-302 has created a subset of patients with durable responses: https://t.co/5P9HHu82EI

[Mayo Clinic Urology @MayoUrology]

Excited to share our second year Urologic Oncology fellow, Dan Roberson, MD, as the featured SUO fellow in the most recent issue of @UrolOncol to honor the amazing accomplishments of SUO fellows. Click the link below to get to know @dsroberson93 better! 
https://t.co/KLCQffnsS3

[Vidit Sharma @vidit_sharma_]

How fast do #rcc tumor thrombi grow? 📈 In our cohort @MayoUrology (n=141), venous tumor thrombi expanded ~1 cm/month (wide range). Faster growth seen with higher Mayo level, sarcomatoid/rhabdoid features & metastasis. These data can guide pre-op imaging & surgical triage.

[European Urology @EUplatinum]

🚨 New in European Urology:
Consolidative surgery after #EnfortumabVedotin +/– ICI in advanced urothelial carcinoma:
✅ 82% downstaging
✅ 43% ypT0N0
✅ 79% stopped systemic therapy
✅ 89% DFS in curative group

📄 https://t.co/Yd52YZKRNk
#BladderCancer #Immunotherapy #Urology

[Mayo Clinic Urology @MayoUrology]

In analysis of over 2,000 open RC patients, Mayo Clinic researchers found that prophylactic iNPWT was associated with lower odds of SSI. Further investigation is warranted though this low cost/risk intervention may reduce morbidity for select patients
https://t.co/IIsWJzfsZC

[Mayo Clinic Urology @MayoUrology]

Bladder tumor hard to reach intraluminally or pt not TURBT candidate? In 59 percutaneous biopsies, 95% diagnostic yield, 93% concordance with TURBT/surgical pathology, 0% bladder perf/leak. Another tool for #bladdercancer providers.
https://t.co/sFLKWkJUsi

[Leilei Xia @LeileiXiaUro]

Thank you for the support, good to be back.

[Mayo Clinic Urology @MayoUrology]

🎉 Exciting news! We're proud to announce our 2026 #UrologicOncology Fellowship Match results!

A huge congratulations to our matched fellows—we can't wait to see you grow & make an impact in the field! 👏🎊

@UroOnc #AUAMatch @Uroweb @SBoorjian @vidit_sharma_ @SUO_YUO

[Mayo Clinic Urology @MayoUrology]

Congrats to @MayoUrology researchers on their ⭐first-ever exploration of a new frontier in advanced urothelial carcinoma!
Historically consolidative surgery was rare in metastatic UC but with unprecedented responses to EV/Pembro the paradigm is shifting.
https://t.co/xGwwechpq5

[Mayo Clinic Urology @MayoUrology]

Excited to welcome AUA Visiting Scholar Dr. Harshit Garg to @MayoClinic! He shared an insightful talk on the transformative role of #AI in medicine — from diagnostics to decision-making. The future is here, and it's intelligent. @AmerUrological #ArtificialIntelligence @Garg_H

[Mayo Clinic Urology @MayoUrology]

On Sunday at #AUA25, don't miss @DSRoberson93 presenting "Venous Tumor Thrombus in Upper Tract Urothelial Carcinoma: A Clinicopathologic, Operative, and Outcomes Analysis of a Contemporary Cohort"
April 27th, 2025: 9:00am
@AmerUrological

[Mayo Clinic Urology @MayoUrology]

Catch the Monday 7am poster session! @DSRoberson93 will present "Renal Cell Carcinoma with Venous Tumor Thrombus: Histologic Characterization of the Non-Neoplastic Parenchymal Microstructure and the Risk of Chronic Kidney Disease Progression". April 28, Casanova 501 #AUA25 #RCC

[Mayo Clinic Urology @MayoUrology]

Don't miss @dsroberson93 presenting "A Prospective Pilot Study of Ex-Vivo High Frequency Ultrasound to Improve Clinical Tumor Staging of Urothelial Carcinoma of the Bladder"
Monday, April 28, 3:30 pm poster session
#AUA24 @AmerUrological

[Mayo Clinic Urology @MayoUrology]

Don't miss @DSRoberson93 presenting "The Association Between Artificial Intelligence Generated Renal Tumor Three-Dimensional Contact Surface Area and Partial Nephrectomy Outcomes"
Tuesday, April 29, 2025, 8:28 am podium
Galileo 1001
#AUA25

[Mayo Clinic Urology @MayoUrology]

Be sure to catch @DSRoberson93 presenting "Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter Analysis"
April 29, 10:18 am podium
Marco Polo 805
#AUA25

[Dan Roberson @DSRoberson93]

@DariaHarlamova @CleClinicUro @PCOMeducation Congrats!